The effect of early inhaled budesonide on pulmonary inflammation in infants with respiratory distress syndrome.
The aim of this pilot study was to determine the effect of early inhaled budesonide on clinical and inflammatory parameters in preterm infants ventilated for respiratory distress syndrome.


CONCLUSIONS
Neither the inflammatory process associated with respiratory distress syndrome nor the progression to bronchopulmonary dysplasia appeared to be altered by treatment with inhaled budesonide.
Inwald
D P
DP
Department of Neonatal Medicine, Homerton Hospital, London E9 6SR, UK. D.Inwald@ich.ucl.ac.uk
Trivedi
K
K
Murch
S H
SH
Costeloe
K
K
D001993:Bronchodilator Agents / Q000627:therapeutic use*; D001997:Bronchopulmonary Dysplasia / Q000188:drug therapy*; D019819:Budesonide / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007249:Inflammation / Q000188:drug therapy; D008137:Longitudinal Studies; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy* / Q000503:physiopathology; D017211:Treatment Failure
D001993:Bronchodilator Agents; D019819:Budesonide